UBS Maintains Neutral on Adient, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Colin Langan maintains a Neutral rating on Adient (NYSE:ADNT) but lowers the price target from $27 to $24.
August 07, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
UBS analyst Colin Langan maintains a Neutral rating on Adient (NYSE:ADNT) but lowers the price target from $27 to $24.
The lowered price target from $27 to $24 by UBS suggests a less optimistic outlook for Adient's stock performance, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100